Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Cancer Investigation

Trends of Female Breast Cancer Burden in China over 25 Years: A Join Point Regression and Age-Period-Cohort Analysis Based on the GBD (1997–2021)

View Full Paper
Ask AI
Bookmark
Share

Authors

YTYuanyan TangJZJia ZhuZLZhengren Liu

Discussion

Loading...

Member takes

Overview

Join point regression analysis revealed trends in female breast cancer incidence and mortality in China, indicating critical public health needs.

Key Points

  • The age standardized incidence rate of female breast cancer in China was 37.12 per 100,000 women in 2021, highlighting a significant health concern.
  • Annual percentage change for breast cancer incidence was 2.42%, while mortality showed a slight decrease of -0.49% over the study period.
  • Join point regression and age-period-cohort models were employed to analyze trends and impacts of age, period, and cohort on breast cancer in China.
  • The findings underscore the urgent need for effective preventive strategies and tailored treatment approaches for breast cancer management.

Cite This Study

Tang et al. (2025) studied this question.

synapsesocial.com/papers/68c192459b7b07f3a061680bhttps://doi.org/10.1080/07357907.2025.2554631
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluation of the breast cancer disease burden in China from 1990 to 2021: based on the Global Burden of Disease Study 20212025 · 1 citations
  2. 2Trends in mortality rates of female breast cancer in China, 2004 to 20212026 · 1 citations
  3. 3Burden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study2026 · 2 citations
  4. 4Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 20222024 · 86 citations
  5. 5Evolving landscape of female cancers along with attributable risk factors in China from 1990 to 2021, and projections to 20402025